INDUCTION CHEMOTHERAPY IN HEAD AND NECK-CANCER WITH CISPLATINUM (C), 5 FLUORO URACIL (F), BLEOMYCIN (B) OR C+

被引：0
|
作者：
BASSOT, F
BRASNU, D
STGUILLY, L
MENARD, M
FABRE, A
DONNADIEU, S
LACCOURREYE, H
JACQUILLAT, C
机构：
[1] HOP SALPETRIERE,DEPT ONCOL,F-75651 PARIS 13,FRANCE
[2] HOP LAENNEC,DEPT HEAD & NECK SURG,F-75340 PARIS 07,FRANCE
来源：
CANCER DRUG DELIVERY | 1986年 / 3卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [31] INDUCTION CHEMOTHERAPY WITH CARBOPLATIN AND FTORAFUR IN ADVANCED HEAD AND NECK-CANCER - A RANDOMIZED STUDY
    TEJEDOR, M
    MURIAS, A
    SORIA, P
    AGUIAR, J
    SALINAS, J
    HERNANDEZ, MA
    MOLANO, F
    GONZALEZ, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (05): : 417 - 421
  • [32] CHEMOTHERAPY OF MALIGNANT METASTASIZED MELANOMA USING THE CISPLATINUM, ADRIAMYCIN, VP16 AND CONTINUOUS 5-FLUORO-URACIL AND BLEOMYCIN IN COMBINATION
    MARAL, J
    JACQUILLAT, C
    THILL, L
    SELLAMI, M
    BANZET, P
    BULLETIN DU CANCER, 1985, 72 (04) : 361 - 362
  • [33] NEOADJUVANT CHEMOTHERAPY WITH CARBOPLATIN 5-FLUOROURACIL IN HEAD AND NECK-CANCER
    DEPONDT, J
    GEHANNO, P
    MARTIN, M
    LELIEVRE, G
    GUERRIER, B
    PEYTRAL, C
    SCHOTT, H
    PELLAECOSSET, B
    ONCOLOGY, 1993, 50 : 23 - 27
  • [34] INDUCTION CHEMOTHERAPY IN HEAD AND NECK-CANCER - RESULTS OF A PHASE-III TRIAL
    MAZERON, JJ
    MARTIN, M
    BRUN, B
    GRIMARD, L
    LELIEVRE, G
    VERGNES, L
    HADDAD, E
    FEUILHADE, F
    PIEDBOIS, P
    STRUNSKI, W
    PEYNEGRE, R
    PIERQUIN, B
    LEBOURGEOIS, JP
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1992, 14 (02): : 85 - 91
  • [35] ASSOCIATION OF LEVELS OF CIRCULATING C1Q BINDING MACROMOLECULES WITH INDUCTION CHEMOTHERAPY RESPONSE IN HEAD AND NECK-CANCER PATIENTS
    SCHANTZ, SP
    SAVAGE, HE
    BROWN, BW
    REUBEN, JM
    HONG, WK
    ROSSEN, RD
    CANCER RESEARCH, 1988, 48 (20) : 5868 - 5873
  • [36] INDUCTION CHEMOTHERAPY WITH CISPLATINUM AND 5-FLUOROURACIL FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    THYSS, A
    SCHNEIDER, M
    SANTINI, J
    CALDANI, C
    VALLICIONI, J
    CHAUVEL, P
    DEMARD, F
    BRITISH JOURNAL OF CANCER, 1986, 54 (05) : 755 - 760
  • [37] RANDOMIZED TRIAL OF CISPLATIN (C), METHOTREXATE (A), BLEOMYCIN (B) AND VINCRISTINE (O) VS ABO IN SQUAMOUS-CELL HEAD AND NECK-CANCER
    CLAVEL, M
    WILDIERS, J
    COGNETTI, F
    VANRIJMENANT, M
    ROSSO, R
    ROSSI, A
    KIRKPATRICK, A
    DALESIO, O
    ROZENCWEIG, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (03): : 404 - 404
  • [38] BLEOMYCIN, ONCOVIN, MITOMYCIN-C, METHOTREXATE (BOMM) +/- ADRIAMYCIN, CISPLATIN, CYCLOPHOSPHAMIDE (APC) IN HEAD AND NECK-CANCER
    BAKER, S
    WHEELER, R
    ENSMINGER, W
    LIEPMAN, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 527 - 527
  • [39] UPTAKE OF 18F-FLUORODEOXYGLUCOSE AND 11C-METHIONINE IN HEAD AND NECK-CANCER
    LINDHOLM, P
    LESKINENKALLIO, S
    MINN, H
    BERGMAN, J
    HAAPARANTA, M
    LEHIKOINEN, P
    NAGREN, K
    RUOTSALAINEN, U
    TERAS, M
    JOENSUU, H
    WEGELIUS, U
    NORDMAN, E
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P21 - P22
  • [40] COMBINATION CHEMOTHERAPY WITH CARBOPLATIN AND BLEOMYCIN FOR ADVANCED AND RECURRENT HEAD AND NECK-CANCER - A PHASE-II STUDY
    GONZALEZVELA, JL
    PANASCI, L
    BLACK, M
    POLLAK, M
    MARGOLESE, R
    JOURNAL OF SURGICAL ONCOLOGY, 1988, 39 (03) : 215 - 216
12345